Yolanda Rosi Helfrich, MD

Assistant Professor, Department of Dermatology

Selected Publications

1. Rosi YL, Lowe L, and Kang S. Treatment of Hidradenitis Suppurativa with Infliximab in a Patient with Crohn's Disease. Journal of Dermatologic Treatment. 2005;16:58-62.
2. Orringer JS, Helfrich YR, Hamilton T, et al. Prevalence of psychotropic medication use among cosmetic and medical dermatology patients: a comparative study. Journal of the American Academy of Dermatology. 2006;54(3)416-419.
3. Orringer JS, Kang S, Maier L, Johnson TM, Sachs DL, Karimipour DJ, Helfrich YR, Hamilton T, Voorhees JJ. A randomized, controlled, split-face clinical trial of 1320-nm Nd:YAG laser therapy in the treatment of acne vulgaris. Journal of the American Academy of Dermatology. 2007;56(3):432-438.
4. Schauber, J, Dorschner RA, Coda AB, Buchau AS, Liu PT, Helfrich YR, Kang S, Elaliah HZ, Zugel U, Bikel DD, Modlin RL, Gallo RL. Injury enhances TLR2 function and cathelicidin expression through a Vitamin D dependent mechanism. Journal of Clinical Investigation. 2007;117(3):803-811.
5. Helfrich YR, Kang S, Hamilton TA, Voorhees JJ. Topical becocalcidiol for the treatment of psoriasis vulgaris: a randomized, placebo-controlled, double-blind, multicentre study. British Journal of Dermatology. 2007;157:369-374.
6. Helfrich YR, Sachs DL, Kang S. Topical Vitamin D3. In: Stephen E. Wolverton, MD, ed. Comprehensive Dermatologic Drug Therapy. 2nd ed. Philadelphia, PA: Elsevier: 2007.
7. Simon NS, Fullen DR, Helfrich YR. "Gooseflesh-like" lesions and hypohidrosis.Archives of Dermatology. 2007;143(10):1323-1328.)
8. Skandamis G, Frohm M, Fullen DR, Helfrich YR. Extensive flaccid bullae with milia. Archives of Dermatology. 2008;144(5):673-867.